Aqua Bio Technology ASA reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was NOK 7.02 million compared to NOK 1.56 million a year ago. Revenue was NOK 7.16 million compared to NOK 1.98 million a year ago.

Net loss was NOK 18.74 million compared to NOK 19.11 million a year ago. Basic loss per share from continuing operations was NOK 0.91 compared to NOK 0.99 a year ago. Diluted loss per share from continuing operations was NOK 0.92 compared to NOK 0.99 a year ago.